Midbrain MRI assessments in progressive supranuclear palsy subtypes.

Related Articles:

• Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome. July 17, 2019 Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome. Parkinsonism Relat Disord. 2019 Jul 08;: Authors: Ahn JH, Kim M, Kim JS, Youn J, Jang W, Oh E, Lee PH, Koh SB, Ahn TB, Cho JW Abstract INTRODUCTION: In the present study, midbrain atrophy and the pons-to-midbrain area ratio (P/M ratio) were investigated as diagnostic markers for presymptomatic progressive…
• Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy. June 11, 2019 Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy. Clin Neurol Neurosurg. 2019 Jun 05;183:105383 Authors: Ghourchian S, Mousavi A, Zamani B, Shahidi G, Rohani M Abstract OBJECTIVES: We aimed to investigate the values of midbrain area in diagnosing Parkinson's Disease (PD) and progressive supranuclear palsy (PSP) by using transcranial sonography (TCS). Disease duration effect on brain sonographic findings…
• Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease. August 20, 2019 Related ArticlesDiagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease. Parkinsonism Relat Disord. 2019 Aug 10;: Authors: Zhang K, Liang Z, Wang C, Zhang X, Yu B, Liu X Abstract BACKGROUND: Progressive supranuclear palsy is a neuropathologically defined disease, and many studies worked on detecting the diagnostic use of Magnetic…
• Midbrain Area Measurements Can Be Used to Distinguish Parkinson’s From PSP, Study Says June 14, 2019 Midbrain area measurements can be used to distinguish patients with Parkinson’s disease from those with progressive supranuclear palsy, a study finds. The study, “Midbrain area for differentiating Parkinson’s disease from progressive supranuclear palsy,” was published in Clinical Neurology and Neurosurgery. Progressive supranuclear palsy (PSP), the second most common Parkinsonian syndrome after Parkinson’s disease, is characterized by gait, balance, speech, vision, behavioral,…
• Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies. October 2, 2019 Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies. Mov Disord. 2019 Sep 30;: Authors: Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Roeber S, Giese A, Grossman M, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Höglinger GU, Movement Disorder…
• Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease. October 22, 2019 Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease. J Neurol Sci. 2019 Aug 31;406:116443 Authors: Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M, Yamada K, Uetani H, Yamashita Y, Wang Y Abstract PURPOSE: To determine whether the susceptibility value in the deep gray matter obtained by quantitative…
• Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. April 17, 2019 Related ArticlesMapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. Sci Rep. 2019 Apr 15;9(1):6079 Authors: Sjöström H, Surova Y, Nilsson M, Granberg T, Westman E, van Westen D, Svenningsson P, Hansson O Abstract There is a need for methods that distinguish Parkinson's disease (PD) from progressive supranuclear palsy (PSP) and multiple…
• Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy. October 12, 2019 Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy. PLoS One. 2019;14(10):e0223621 Authors: Picillo M, Cuoco S, Carotenuto I, Abate F, Erro R, Volpe G, Pellecchia MT, Catricalà E, Cappa S, Barone P Abstract BACKGROUND: Progressive Supranuclear Palsy (PSP) patients present language disturbances in tasks like naming, repetition, reading, word comprehension and semantic association compared…
• Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. August 20, 2019 Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disord. 2019 Aug;34(8):1087-1088 Authors: Stamelou M PMID: 31424622 [PubMed - in process]
• The language profile of progressive supranuclear palsy. March 19, 2019 Related ArticlesThe language profile of progressive supranuclear palsy. Cortex. 2019 Feb 22;115:294-308 Authors: Catricalà E, Boschi V, Cuoco S, Galiano F, Picillo M, Gobbi E, Miozzo A, Chesi C, Esposito V, Santangelo G, Pellecchia MT, Borsa VM, Barone P, Garrard P, Iannaccone S, Cappa SF Abstract A progressive speech/language disorder, such as the non fluent/agrammatic variant of primary progressive aphasia…
• "One line": A method for differential diagnosis of parkinsonian syndromes. June 22, 2019 "One line": A method for differential diagnosis of parkinsonian syndromes. Acta Neurol Scand. 2019 Jun 21;: Authors: Sako W, Abe T, Haji S, Murakami N, Osaki Y, Izumi Y, Harada M, Kaji R Abstract BACKGROUND: Neurological findings are important for the differential diagnosis of Parkinson's disease (PD), multiple system atrophy with predominant parkinsonian features (MSA-P), and progressive supranuclear palsy (PSP).…
• Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson's disease: a systematic review and meta-analysis. May 6, 2019 Related ArticlesMetabolic pattern analysis of 18F-FDG PET as a marker for Parkinson's disease: a systematic review and meta-analysis. Rev Neurosci. 2019 May 03;: Authors: Gu SC, Ye Q, Yuan CX Abstract A large number of articles have assessed the diagnostic accuracy of the metabolic pattern analysis of [18F]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in Parkinson's disease (PD); however, different studies…
• Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study. October 18, 2019 Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study. Parkinsonism Relat Disord. 2019 Oct 01;68:40-45 Authors: Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I, Lopez-Sendon Moreno JL, Parees-Moreno I, Monreal-Laguillo E, Pérez-Torre P, Toledano Delgado R, García Ribas G, Sastre Bataller I, Masjuan J, Martinez-Castrillo JC, Walter U Abstract INTRODUCTION: Substantia nigra hyperechogenicity…
• Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism. October 31, 2019 Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism. Parkinsonism Relat Disord. 2019 Oct 22;69:23-29 Authors: Nigro S, Barbagallo G, Bianco MG, Morelli M, Arabia G, Quattrone A, Gasparini S, Cascini GL, Quattrone A Abstract INTRODUCTION: Track density imaging (TDI) has been proven to be a useful approach able to investigate…
• Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies. October 17, 2019 Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies. Radiology. 2019 Oct 15;:190406 Authors: Spotorno N, Hall S, Irwin DJ, Rumetshofer T, Acosta-Cabronero J, Deik AF, Spindler MA, Lee EB, Trojanowski JQ, van Westen D, Nilsson M, Grossman M, Nestor PJ, McMillan CT, Hansson O Abstract Background The differential diagnosis of progressive supranuclear palsy (PSP) and Lewy body disorders,…
• Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. June 4, 2019 Related ArticlesStimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. Brain Stimul. 2019 May 24;: Authors: Benussi A, Dell'Era V, Cantoni V, Turrone R, Pilotto A, Alberici A, Cotelli MS, Rizzetti C, Padovani A, Borroni B Abstract OBJECTIVE: To determine whether motor cortex inhibition by stimulation over the cerebellum…
• Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. July 11, 2019 Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain. 2019 Jul 09;: Authors: Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL Abstract Clinical diagnosis of multiple system atrophy is challenging and many patients with Lewy body disease (i.e. Parkinson's disease or dementia with Lewy bodies) or progressive supranuclear palsy are misdiagnosed as…
• Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load. August 1, 2019 Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load. J Magn Reson Imaging. 2019 Jul 31;: Authors: Fang E, Ann CN, Maréchal B, Lim JX, Tan SYZ, Li H, Gan J, Tan EK, Chan LL Abstract BACKGROUND: Periventricular leukoaraiosis may be an important pathological change in postural instability gait disorder (PIGD),…
• The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. July 13, 2019 The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy. Mov Disord. 2019 Jul 12;: Authors: Jabbari E, Woodside J, Tan MMX, Pavese N, Bandmann O, Ghosh BCP, Massey LA, Capps E, Warner TT, Lees AJ, Revesz T, Holton JL, Williams NM, Grosset DG, Morris HR Abstract BACKGROUND: Studies on early-onset presentations of progressive supranuclear palsy (PSP) have been limited…
• Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly. July 21, 2019 Related ArticlesProgressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly. Rev Esp Geriatr Gerontol. 2019 Jul 16;: Authors: Fernández-Ferreira R, García-Santos RA, Rodríguez-Violante M, López-Martínez C, Becerra-Laparra IK, Torres-Pérez ME Abstract INTRODUCTION: Progressive supranuclear palsy (PSP) is a syndrome characterized by progressive parkinsonism with early falls due to postural instability, typically vertical gaze supranuclear ophthalmoplegia, pseudobulbar dysfunction,…